# Claim table — Del Bigtree / Angus Dalgleish “turbo cancer” Reel

| Claim | Evidence label | Finding |
|---|---|---|
| Del Bigtree asked Angus Dalgleish whether COVID vaccination is creating “turbo cancers,” and Dalgleish answered yes. | Confirmed source claim/opinion. | Captured Facebook metadata and transcript support this. |
| COVID vaccines have been shown to cause or accelerate cancer / “turbo cancers.” | Not established. | NCI states there is no evidence COVID-19 vaccines cause cancer, recurrence or disease progression; FactCheck.org and cited cancer experts say current evidence does not show a causal pattern. |
| COVID vaccines change DNA or integrate randomly into the genome. | Not established by cited cancer-agency sources. | NCI says COVID-19 vaccines do not change DNA. Dalgleish’s integration claim is a mechanism allegation, not a demonstrated clinical cancer cause in this source package. |
| IgG4/class-switch changes after repeated mRNA vaccination are real research topics. | Research kernel / open question. | Studies describe spike-specific IgG subclass shifts and functional changes; they do not by themselves prove cancer immune escape or “turbo cancer.” |
| mRNA cancer-vaccine mouse/immunology studies prove COVID vaccines stimulate cancer. | Misleading extrapolation. | FactCheck.org notes experts said a key mouse melanoma mRNA-vaccine study was misrepresented; it did not show modified mRNA promoted tumour growth. |
| Case reports or anecdotes after vaccination prove causality. | Weak evidence / hypothesis generating. | Case reports can raise questions but cannot establish causation without epidemiologic patterns, controls and mechanism. |
| People with cancer are higher-risk for severe COVID-19. | Established evidence / official guidance. | NCI and oncology reviews describe higher severe-COVID risk in cancer/immunosuppressed populations. |
| A cancer patient should stop or refuse vaccines/treatment based on the Reel. | Unsafe unsupported treatment advice. | This source-check gives no personal medical instruction; decisions belong with oncology/infectious-disease clinicians. |